Pryce, Gareth <br/><br/>
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis.  [electronic resource] 

 -  Brain : a journal of neurology  Oct 2003 
 - 2191-202 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-8950 
<br/><br/><label>Standard No.: </label>10.1093/brain/awg224  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Aspartic Acid--analogs & derivatives<br/>Axons--chemistry<br/>Benzoxazines<br/>Cannabinoids--therapeutic use<br/>Cyclohexanols--therapeutic use<br/>Dizocilpine Maleate--therapeutic use<br/>Encephalomyelitis, Autoimmune, Experimental<br/>Excitatory Amino Acid Agonists--therapeutic use<br/>Gene Deletion<br/>Humans<br/>Mice<br/>Mice, Transgenic<br/>Monomeric GTP-Binding Proteins--genetics<br/>Morpholines--therapeutic use<br/>Multiple Sclerosis--drug therapy<br/>N-Methylaspartate--therapeutic use<br/>Naphthalenes--therapeutic use<br/>Nerve Degeneration<br/>Nuclear Proteins--genetics<br/>Receptors, Cannabinoid<br/>Receptors, Drug--agonists<br/>Receptors, N-Methyl-D-Aspartate--antagonists & inhibitors<br/>Retina--drug effects<br/>Saccharomyces cerevisiae Proteins<br/>Spinal Cord--pathology<br/>Uveitis--immunology